Developer of a drug discovery platform designed to elucidate human biology and create sophisticated therapeutics that at
Drug Discovery📍 Cambridge, MAFounded 2016
Current Valuation
$525M
as of 2022-Q1
PRIVATE
Developer of a drug discovery platform designed to elucidate human biology and create sophisticated therapeutics that attack the fundamental drivers of serious human diseases.
Company Profile
Founded
2016
HQ
Cambridge, MA
Employees
51
Total Raised
$300.07M
Last Round
Series C — $175M (Mar 2022)
IPO Status
private
Fundraising Status
Series C · $175M · 4y 5mo ago
privateTotal raised $300.07M
Secondary Market
Implied price / share
$5
Last round price / share
$2.04
vs last round
+145.1%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$175M
Mar 2022
—
$525M
BiotechnologyLife ScienceTherapeuticsGenetics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.